Merck Expands Protein A Capabilities with JSR Chromatography Acquisition
April 16, 2026
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.
False
Advertisement
2026
Cell and Gene Roundup: CAR T Breaks New Ground
April 15, 2026
A campus-built therapy enters clinical trials as researchers refine gene editing and uncover new ways to control gene expression
5 min read
Navigating Formulation Change in the EU
April 15, 2026
How to turn regulatory complexity into strategic strength
7 min read
Jonathan Van-Tam on COVID’s Next Phase
April 14, 2026
Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19
4 min read
FDA Fast-Tracks Off-the-Shelf CAR-T for Aggressive T-Cell Cancers
April 14, 2026
WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas.
1 min read
CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease
April 13, 2026
An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial
2 min read
New Iron-Tracking Tool Could Boost Cartilage Regeneration Therapies
April 10, 2026
MIT-led team develops rapid, non-destructive method to predict stem cell quality during manufacturing
1 min read
Trends and Challenges in Nitrosamine Testing: Part Two – Analytical Challenges
April 10, 2026
Sample preparation, limits of detection, and structural determination – our experts return for part two to discuss the main analytical challenges associated with nitrosamines
11 min read
Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda
April 9, 2026
New modeling study shows curative treatments may be viable in low-income settings if costs are scaled and societal benefits included
1 min read
GLP-1 Analysis: Riding the Wave of Peptide Innovation
April 9, 2026
The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.
12 min read
